Dovitinib

• Description :

  A novel, multitargeted RTK inhibitor of class III, IV, and V RTKs.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  392.4294

• Molecular Formula :

  C21H21FN6O

• Notes :

  Research use only, not for human use.

• Receptor :

  C-Kit|FGFR1|FGFR3|FLT3|VEGFR3/FLT4

• CAS Number :

  405169-16-6